GT Apeiron Therapeutics jobs and careers
Shanghai, Shanghai, China
About GT Apeiron Therapeutics
Apeiron Therapeutics intends to develop breakthrough investigational medicines by harnessing the power of artificial intelligence which drastically increases efficiency throughout the drug discovery process, from target selection, hit identification, lead optimization to pre-clinical studies and clinical trials.
Founded in 2019 by Alan Au.
- Founded
- 2019
- Employees
- 11 to 50
- Total funding
- $44.5M
- Headquarters
- Shanghai
Leadership
The top of GT Apeiron Therapeutics's org chart, with how many people report into each leader.
Mingxi Li
CEO
11 reports
Fred Aswad
SVP, Biology
5 reports
Xiaohui Gu
Co-Founder, Senior Vice President of Research & Head of Chemistry
2 reports
Lucy Yu
Human Resources Director
1 report
Board
David Norwood
Honorary Chairman
Ruilin Song
Advisor
Yuk Lam Lo
Advisor
Honggang Bi
Advisor
Keith Lenden
Advisor
Jobs at GT Apeiron Therapeutics
No open positions right now. Explore more companies on TheJobsMap.